Anktiva plus BCG aims to treat BCG-unresponsive NMIBC with papillary disease, potentially reducing radical cystectomy need. The treatment showed high rates of surgery avoidance and disease-free ...

A statistical modeling study estimated that 72% to 94% of papillary thyroid cancer diagnoses from 1991 to 2019 were overdiagnosed. Women had substantially higher rates of overdiagnosis. Reducing ...

High- vs moderate-activity radioactive iodine does not improve recurrence-free survival in intermediate-risk papillary thyroid cancer.

The TAR-200 system offering sustained intravesical gemcitabine release shows favorable response and tolerability in both the CIS and papillary-only subgroups with BCG-unresponsive high-risk NMIBC. TAR ...

Case reports and systematic review found the combination of surgery, chemotherapy, and radiotherapy can effectively manage diffuse large B-cell lymphoma (DLBCL) associated with papillary thyroid ...

This transcript has been edited for clarity. Kaniksha Desai, MD: Welcome to the Thyroid Stimulating Podcast. This podcast was created in partnership with the American Thyroid Association to discuss up ...

Please provide your email address to receive an email when new articles are posted on . Thyroid cancer-related fear and worry scores declined for adults 9 months after a thyroidectomy compared with ...

In a 10-center study, microwave ablation offered progression free survival rates and fewer complications than surgery in the treatment of a form of thyroid cancer known as papillary thyroid carcinoma ...

Some flame retardants used in many home products appear to be associated with the most common type of thyroid cancer, papillary thyroid cancer (PTC), according to a new study being presented Saturday ...